Scorpius Holdings Inc (SCPX)
0.0315
0.00 (0.00%)
USD |
NYAM |
Jun 24, 16:00
Scorpius Holdings Shareholders Equity (Quarterly): 28.60M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 28.60M |
December 31, 2023 | 31.40M |
September 30, 2023 | 36.29M |
June 30, 2023 | 48.73M |
March 31, 2023 | 61.94M |
December 31, 2022 | 73.92M |
September 30, 2022 | 84.47M |
June 30, 2022 | 96.64M |
March 31, 2022 | 105.84M |
December 31, 2021 | 113.11M |
September 30, 2021 | 124.89M |
June 30, 2021 | 131.39M |
March 31, 2021 | 137.30M |
December 31, 2020 | 116.24M |
September 30, 2020 | 121.54M |
June 30, 2020 | 47.71M |
March 31, 2020 | 27.03M |
December 31, 2019 | 13.57M |
September 30, 2019 | 16.63M |
June 30, 2019 | 22.28M |
March 31, 2019 | 26.63M |
December 31, 2018 | 30.29M |
September 30, 2018 | 24.69M |
Date | Value |
---|---|
June 30, 2018 | 27.44M |
March 31, 2018 | 7.637M |
December 31, 2017 | 7.371M |
September 30, 2017 | 7.991M |
June 30, 2017 | 10.17M |
March 31, 2017 | 12.12M |
December 31, 2016 | 8.797M |
September 30, 2016 | 7.026M |
June 30, 2016 | 2.956M |
March 31, 2016 | 5.702M |
December 31, 2015 | 4.050M |
September 30, 2015 | 10.03M |
June 30, 2015 | 14.99M |
March 31, 2015 | 19.40M |
December 31, 2014 | 11.76M |
September 30, 2014 | 15.03M |
June 30, 2014 | 17.49M |
March 31, 2014 | 20.01M |
December 31, 2013 | 21.99M |
September 30, 2013 | 23.85M |
June 30, 2013 | 1.265M |
March 31, 2013 | 2.745M |
December 31, 2012 | -1.439M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
13.57M
Minimum
Dec 2019
137.30M
Maximum
Mar 2021
71.98M
Average
67.93M
Median
Shareholders Equity (Quarterly) Benchmarks
Biolase Inc | 0.269M |
GT Biopharma Inc | 5.312M |
Akoya Biosciences Inc | 32.72M |
NovaBay Pharmaceuticals Inc | 0.16M |
Palatin Technologies Inc | 1.579M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 50.50M |
Total Liabilities (Quarterly) | 25.24M |
Debt to Equity Ratio | 0.0728 |
Current Ratio | 0.3768 |
Net Debt Paydown Yield | -7.13% |